没有进展的生存率估计是由特定的审查规则所塑造的:癌症随机试验中PFS作为终点的PFS影响
Vadim Lesan1, Timothée Olivier2, Vinay Prasad3
1Hematology and Oncology Department, Saarland University Hospital, Kirrberger Street 100, 66421, Homburg, Germany.
European journal of cancer (Oxford, England : 1990)
|March 28, 2024
概括
卡普兰-梅尔分析假设被审查的患者与跟踪的患者没有区别. 在一项试验中,不同的审查规则大大改变了无进展生存 (PFS) 估计,突出了需要可靠的PFS终点的需要.
科学领域:
- 在瘤学瘤学.
- 生物统计学 生物统计学
- 临床试验 临床试验
背景情况:
- 卡普兰-梅尔分析是估计生存分布的标准方法.
- 审查,这涉及处理丢失的随访或不完整数据的患者,是生存分析的关键方面.
- 审查规则的差异可能会对研究结果产生重大影响,特别是在瘤学中.
研究的目的:
- 调查为什么不同的审查规则在最近的一项瘤临床试验中大大改变了无进展生存 (PFS) 估计.
- 提供瘤学临床试验中审查方法的概述.
- 为提高PFS作为临床终点的可靠性提供建议.
主要方法:
- 这项研究检查了一项最近的临床试验,其中应用了两个不同的审查规则来估计无进展生存期 (PFS).
- 对由试验者的首选规则产生的PFS估计进行了比较分析,与美国食品和药物管理局 (FDA) 推的规则相比.
- 评论回顾了卡普兰-梅尔分析的原则,以及对生存数据的审查的影响.
主要成果:
- 应用不同的审查规则导致实验组的PFS估计发生了重大变化,将中位数从32个月增加到43个月.
- 对于控制部门的PFS估计在两个审查规则集之间基本没有变化.
- 这种差异强调了PFS估计对所选择的审查方法的敏感性.
结论:
- 审查规则的选择可以深刻影响瘤学临床试验中无进展生存 (PFS) 估计.
- 标准化或仔细考虑审查方法对于可靠地解释PFS至关重要.
- 需要进一步的研究和共识,以确保PFS在癌症研究中保持强大和可靠的终点.
相关概念视频
01:09Censoring Survival Data
88
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
88
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
01:24Kaplan-Meier Approach
136
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
136
01:15Assumptions of Survival Analysis
126
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
126
01:20Comparing the Survival Analysis of Two or More Groups
181
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
181
01:09Truncation in Survival Analysis
205
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
205